In our work, we focus less on cannabis cultivation than on research into standardized pharmaceutical cannabis products, without which a stable and constant supply would be impossible to guarantee.
To provide the best possible treatment to critically ill patients, we combine pharmaceutical research with the development of appropriate cannabinoid therapies.
To create new possibilities for therapy. We provide easy access to cannabinoid treatments for patients, doctors and pharmacists.
The goal is to develop the pharmaceutical industry to establish standardized, prescription cannabinoid drugs, using new patents and clinical trials.